Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$6.46M Sell
37,178
-2,000
-5% -$354K 0.46% 61
2017
Q3
$7.3M Sell
39,178
-3,643
-9% -$645K 0.47% 52
2017
Q2
$7.38M Sell
42,821
-4,978
-10% -$810K 0.45% 56
2017
Q1
$7.84M Buy
47,799
+32,848
+220% +$5.46M 0.43% 58
2016
Q4
$2.19M Sell
14,951
-4,049
-21% -$609K 0.15% 161
2016
Q3
$3.17M Sell
19,000
-2,610
-12% -$441K 0.23% 111
2016
Q2
$3.29M Sell
21,610
-18,743
-46% -$2.91M 0.25% 106
2016
Q1
$6.05M Sell
40,353
-5,991
-13% -$890K 0.38% 75
2015
Q4
$7.52M Buy
+46,344
New +$7.28M 0.45% 57
2015
Q1
Sell
-111,600
Closed -$17.8M 616
2014
Q4
$17.8M Sell
111,600
-22,033
-16% -$3.43M 0.53% 40
2014
Q3
$18.8M Sell
133,633
-514
-0.4% -$67.1K 0.5% 44
2014
Q2
$15.9M Buy
134,147
+25,198
+23% +$2.92M 0.47% 46
2014
Q1
$13.4M Buy
+108,949
New +$13.2M 0.45% 57

Other funds holding AMGN

GLG LLC's AMGN Position: Q4 2017 in Review

GLG LLC reduced its Amgen (AMGN) stake by 5.1% in Q4 2017, selling an estimated $354K and leaving 37,178 shares worth $6.46M. The position accounts for 0.46% of the portfolio, ranked #61.

GLG LLC first reported a position in AMGN in Q1 2014 and has held it in 13 quarters since. The position peaked at $18.8M in Q3 2014. 1,734 funds tracked by Wall St. Rank hold AMGN as of Q4 2017.

  • GLG LLC held 37,178 shares of Amgen worth $6.46M as of Q4 2017.
  • GLG LLC sold 2,000 Amgen shares in Q4 2017, an estimated $354K.
  • Amgen made up 0.46% of GLG LLC's portfolio in Q4 2017, its #61 holding.
  • GLG LLC first reported a position in Amgen in Q1 2014 and has held it in 13 quarters since.
  • GLG LLC's Amgen position peaked at $18.8M in Q3 2014.
  • 1,734 funds tracked by Wall St. Rank held Amgen as of Q4 2017.

Based on GLG LLC's 13F filing for Q4 2017, filed 14 Feb 2018.